
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE53446C8AF4182305446C001095BF15.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="neurology">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Neurology">
<meta name="citation_title" content="Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease">
<meta name="citation_author" content="Sohyun Yim">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author" content="Seongbeom Park">
<meta name="citation_author_institution" content="BeauBrain Healthcare, Inc., Seoul, South Korea;">
<meta name="citation_author" content="Kyoungyoon Lim">
<meta name="citation_author_institution" content="BeauBrain Healthcare, Inc., Seoul, South Korea;">
<meta name="citation_author" content="Heekyung Kang">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author" content="Daeun Shin">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author" content="Hyunjin Jo">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author" content="Hyemin Jang">
<meta name="citation_author_institution" content="Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, South Korea;">
<meta name="citation_author" content="Michael W Weiner">
<meta name="citation_author_institution" content="Department of Radiology and Biomedical Imaging, University of California, San Francisco;">
<meta name="citation_author" content="Henrik Zetterberg">
<meta name="citation_author_institution" content="Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;">
<meta name="citation_author_institution" content="Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;">
<meta name="citation_author_institution" content="Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom;">
<meta name="citation_author_institution" content="UK Dementia Research Institute, UCL, London, United Kingdom;">
<meta name="citation_author_institution" content="Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China;">
<meta name="citation_author_institution" content="Wisconsin Alzheimer&#x27;s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison;">
<meta name="citation_author" content="Kaj Blennow">
<meta name="citation_author_institution" content="Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;">
<meta name="citation_author_institution" content="Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;">
<meta name="citation_author_institution" content="Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, France;">
<meta name="citation_author_institution" content="Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China;">
<meta name="citation_author" content="Fernando Gonzalez-Ortiz">
<meta name="citation_author_institution" content="Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;">
<meta name="citation_author_institution" content="Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;">
<meta name="citation_author" content="Nicholas J Ashton">
<meta name="citation_author_institution" content="Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;">
<meta name="citation_author_institution" content="King&#x27;s College London, Institute of Psychiatry, Psychology and Neuroscience Maurice Wohl Institute Clinical Neuroscience Institute, United Kingdom;">
<meta name="citation_author_institution" content="NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, United Kingdom;">
<meta name="citation_author_institution" content="Centre for Age-Related Medicine, Stavanger University Hospital, Norway;">
<meta name="citation_author" content="Sung Hoon Kang">
<meta name="citation_author_institution" content="Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea;">
<meta name="citation_author" content="Jihwan Yun">
<meta name="citation_author_institution" content="Department of Neurology, KyungHee University College of Medicine, Kyung Hee University Hospital, Seoul, South Korea;">
<meta name="citation_author" content="Min Young Chun">
<meta name="citation_author_institution" content="Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea;">
<meta name="citation_author_institution" content="Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Gyeonggi-do, South Korea;">
<meta name="citation_author" content="Eun-Joo Kim">
<meta name="citation_author_institution" content="Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, South Korea;">
<meta name="citation_author" content="Hee Jin Kim">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author_institution" content="Alzheimer&#x27;s Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;">
<meta name="citation_author_institution" content="Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea; and">
<meta name="citation_author_institution" content="Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.">
<meta name="citation_author" content="Duk L Na">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author_institution" content="Alzheimer&#x27;s Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;">
<meta name="citation_author" content="Jun Pyo Kim">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author_institution" content="Alzheimer&#x27;s Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;">
<meta name="citation_author" content="Sang Won Seo">
<meta name="citation_author_institution" content="Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;">
<meta name="citation_author_institution" content="Alzheimer&#x27;s Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;">
<meta name="citation_author_institution" content="Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea; and">
<meta name="citation_author_institution" content="Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.">
<meta name="citation_author" content="Kichang Kwak">
<meta name="citation_author_institution" content="BeauBrain Healthcare, Inc., Seoul, South Korea;">
<meta name="citation_author" content="for the K-ROAD study and the Alzheimer&#x27;s Disease Neuroimaging Initiative">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="105">
<meta name="citation_issue" content="6">
<meta name="citation_firstpage" content="e213954">
<meta name="citation_doi" content="10.1212/WNL.0000000000213954">
<meta name="citation_pmid" content="40829110">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/pdf/WNL-2025-200353.pdf">
<meta name="description" content="Identifying β-amyloid (Aβ) positivity is crucial for selecting candidates for Aβ-targeted therapies in early-stage Alzheimer disease (AD). While Aβ PET is accurate, its high cost limits routine use. Plasma p-tau217 testing offers a less invasive ...">
<meta name="og:title" content="Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Identifying β-amyloid (Aβ) positivity is crucial for selecting candidates for Aβ-targeted therapies in early-stage Alzheimer disease (AD). While Aβ PET is accurate, its high cost limits routine use. Plasma p-tau217 testing offers a less invasive ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12367417">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1212/WNL.0000000000213954"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/WNL-2025-200353.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367417%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12367417/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12367417/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-neurology.png" alt="Neurology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Neurology" title="Link to Neurology" shape="default" href="http://n.neurology.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Neurology</button></div>. 2025 Aug 19;105(6):e213954. doi: <a href="https://doi.org/10.1212/WNL.0000000000213954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1212/WNL.0000000000213954</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Neurology%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neurology%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Neurology%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Neurology%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yim%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Sohyun Yim</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Sohyun Yim</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yim%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sohyun Yim</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Seongbeom Park</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Seongbeom Park</span></h3>
<div class="p">
<sup>2</sup>BeauBrain Healthcare, Inc., Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Seongbeom Park</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lim%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Kyoungyoon Lim</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Kyoungyoon Lim</span></h3>
<div class="p">
<sup>2</sup>BeauBrain Healthcare, Inc., Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lim%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kyoungyoon Lim</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Heekyung Kang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Heekyung Kang</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Heekyung Kang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shin%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Daeun Shin</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Daeun Shin</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shin%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daeun Shin</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jo%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hyunjin Jo</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hyunjin Jo</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jo%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hyunjin Jo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Hyemin Jang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Hyemin Jang</span></h3>
<div class="p">
<sup>3</sup>Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hyemin Jang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weiner%20MW%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Michael W Weiner</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Michael W Weiner</span></h3>
<div class="p">
<sup>4</sup>Department of Radiology and Biomedical Imaging, University of California, San Francisco;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weiner%20MW%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael W Weiner</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zetterberg%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Henrik Zetterberg</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Henrik Zetterberg</span></h3>
<div class="p">
<sup>5</sup>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;</div>
<div class="p">
<sup>6</sup>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;</div>
<div class="p">
<sup>7</sup>Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom;</div>
<div class="p">
<sup>8</sup>UK Dementia Research Institute, UCL, London, United Kingdom;</div>
<div class="p">
<sup>9</sup>Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China;</div>
<div class="p">
<sup>10</sup>Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zetterberg%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Henrik Zetterberg</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>7,</sup><sup>8,</sup><sup>9,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blennow%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Kaj Blennow</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Kaj Blennow</span></h3>
<div class="p">
<sup>5</sup>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;</div>
<div class="p">
<sup>6</sup>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;</div>
<div class="p">
<sup>11</sup>Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, France;</div>
<div class="p">
<sup>12</sup>Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blennow%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kaj Blennow</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>11,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gonzalez-Ortiz%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Fernando Gonzalez-Ortiz</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Fernando Gonzalez-Ortiz</span></h3>
<div class="p">
<sup>5</sup>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;</div>
<div class="p">
<sup>6</sup>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gonzalez-Ortiz%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fernando Gonzalez-Ortiz</span></a>
</div>
</div>
<sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ashton%20NJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Nicholas J Ashton</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Nicholas J Ashton</span></h3>
<div class="p">
<sup>5</sup>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;</div>
<div class="p">
<sup>13</sup>King's College London, Institute of Psychiatry, Psychology and Neuroscience Maurice Wohl Institute Clinical Neuroscience Institute, United Kingdom;</div>
<div class="p">
<sup>14</sup>NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, United Kingdom;</div>
<div class="p">
<sup>15</sup>Centre for Age-Related Medicine, Stavanger University Hospital, Norway;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ashton%20NJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicholas J Ashton</span></a>
</div>
</div>
<sup>5,</sup><sup>13,</sup><sup>14,</sup><sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kang%20SH%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Sung Hoon Kang</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Sung Hoon Kang</span></h3>
<div class="p">
<sup>16</sup>Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kang%20SH%22%5BAuthor%5D" class="usa-link"><span class="name western">Sung Hoon Kang</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yun%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Jihwan Yun</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Jihwan Yun</span></h3>
<div class="p">
<sup>17</sup>Department of Neurology, KyungHee University College of Medicine, Kyung Hee University Hospital, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yun%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jihwan Yun</span></a>
</div>
</div>
<sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chun%20MY%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Min Young Chun</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Min Young Chun</span></h3>
<div class="p">
<sup>18</sup>Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea;</div>
<div class="p">
<sup>19</sup>Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Gyeonggi-do, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chun%20MY%22%5BAuthor%5D" class="usa-link"><span class="name western">Min Young Chun</span></a>
</div>
</div>
<sup>18,</sup><sup>19</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20EJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Eun-Joo Kim</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Eun-Joo Kim</span></h3>
<div class="p">
<sup>20</sup>Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20EJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Eun-Joo Kim</span></a>
</div>
</div>
<sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20HJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Hee Jin Kim</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Hee Jin Kim</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">
<sup>21</sup>Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;</div>
<div class="p">
<sup>22</sup>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea; and</div>
<div class="p">
<sup>23</sup>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20HJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Hee Jin Kim</span></a>
</div>
</div>
<sup>1,</sup><sup>21,</sup><sup>22,</sup><sup>23</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Na%20DL%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Duk L Na</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Duk L Na</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">
<sup>21</sup>Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Na%20DL%22%5BAuthor%5D" class="usa-link"><span class="name western">Duk L Na</span></a>
</div>
</div>
<sup>1,</sup><sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20JP%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Jun Pyo Kim</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Jun Pyo Kim</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">
<sup>21</sup>Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20JP%22%5BAuthor%5D" class="usa-link"><span class="name western">Jun Pyo Kim</span></a>
</div>
</div>
<sup>1,</sup><sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Seo%20SW%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Sang Won Seo</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Sang Won Seo</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div class="p">
<sup>21</sup>Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;</div>
<div class="p">
<sup>22</sup>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea; and</div>
<div class="p">
<sup>23</sup>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Seo%20SW%22%5BAuthor%5D" class="usa-link"><span class="name western">Sang Won Seo</span></a>
</div>
</div>
<sup>1,</sup><sup>21,</sup><sup>22,</sup><sup>23,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kwak%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Kichang Kwak</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Kichang Kwak</span></h3>
<div class="p">
<sup>2</sup>BeauBrain Healthcare, Inc., Seoul, South Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kwak%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kichang Kwak</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>; <span class="collab">for the K-ROAD study and the Alzheimer's Disease Neuroimaging Initiative</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;</div>
<div id="aff2">
<sup>2</sup>BeauBrain Healthcare, Inc., Seoul, South Korea;</div>
<div id="aff3">
<sup>3</sup>Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, South Korea;</div>
<div id="aff4">
<sup>4</sup>Department of Radiology and Biomedical Imaging, University of California, San Francisco;</div>
<div id="aff5">
<sup>5</sup>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden;</div>
<div id="aff6">
<sup>6</sup>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;</div>
<div id="aff7">
<sup>7</sup>Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom;</div>
<div id="aff8">
<sup>8</sup>UK Dementia Research Institute, UCL, London, United Kingdom;</div>
<div id="aff9">
<sup>9</sup>Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China;</div>
<div id="aff10">
<sup>10</sup>Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison;</div>
<div id="aff11">
<sup>11</sup>Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, France;</div>
<div id="aff12">
<sup>12</sup>Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China;</div>
<div id="aff13">
<sup>13</sup>King's College London, Institute of Psychiatry, Psychology and Neuroscience Maurice Wohl Institute Clinical Neuroscience Institute, United Kingdom;</div>
<div id="aff14">
<sup>14</sup>NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, United Kingdom;</div>
<div id="aff15">
<sup>15</sup>Centre for Age-Related Medicine, Stavanger University Hospital, Norway;</div>
<div id="aff16">
<sup>16</sup>Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea;</div>
<div id="aff17">
<sup>17</sup>Department of Neurology, KyungHee University College of Medicine, Kyung Hee University Hospital, Seoul, South Korea;</div>
<div id="aff18">
<sup>18</sup>Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea;</div>
<div id="aff19">
<sup>19</sup>Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Gyeonggi-do, South Korea;</div>
<div id="aff20">
<sup>20</sup>Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, South Korea;</div>
<div id="aff21">
<sup>21</sup>Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea;</div>
<div id="aff22">
<sup>22</sup>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea; and</div>
<div id="aff23">
<sup>23</sup>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</div>
<div class="author-notes p">
<div class="fn" id="corresp1">
<sup>✉</sup><p class="display-inline"><strong>Correspondence</strong> Dr. Seo <span>sangwonseo@empal.com</span> or Dr. Kwak <span>kichang.kwak@beaubrain.bio</span></p>
</div>
<div class="fn" id="fn1_pmc"><p>The Article Processing Charge was funded by the authors.</p></div>
<div class="fn" id="fn2"><p>K-ROAD Coinvestigators are listed online at <a href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000213954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Neurology.org</a>.</p></div>
<div class="fn" id="fn3"><p>Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found in the Appendix at <a href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000213954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Neurology.org/N</a>.</p></div>
<div class="fn" id="fn4"><p>Submitted and externally peer reviewed. The handling editor was Assistant Editor Marcello Moccia, MD, PhD and Associate Editor for Editorial Education Bradford Worrall, MD, MSc, FAAN.</p></div>
<div class="fn" id="fn1">
<sup>*</sup><p class="display-inline">These authors contributed equally to this article as co-corresponding authors.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jan 22; Accepted 2025 Jun 18; Issue date 2025 Sep 23.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</a>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12367417  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40829110/" class="usa-link">40829110</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background and Objectives</h3>
<p>Identifying β-amyloid (Aβ) positivity is crucial for selecting candidates for Aβ-targeted therapies in early-stage Alzheimer disease (AD). While Aβ PET is accurate, its high cost limits routine use. Plasma p-tau217 testing offers a less invasive option but also incurs additional costs. Structural brain MRI, routinely used in cognitive assessments, can identify features predictive of Aβ positivity without extra expense. We evaluated a 2-stage workflow integrating MRI-based features and plasma p-tau217 to efficiently predict Aβ PET positivity in early-stage AD.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>This prospective cohort study included participants with mild cognitive impairment (MCI) or early Alzheimer-type dementia (ATD) from the Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD; Korea) and Alzheimer's Disease Neuroimaging Initiative (ADNI; US) cohorts. Eligible participants had a Clinical Dementia Rating score of 0.5, along with MRI, plasma p-tau217, and Aβ PET data. A random forest classifier predicting Aβ PET positivity was developed using MRI-based brain atrophy patterns and APOE ε4 status. Participants were stratified into low-risk, intermediate-risk, and high-risk groups; plasma p-tau217 testing was performed only in intermediate-risk individuals. Outcomes included positive predictive value (PPV), negative predictive value (NPV), and overall accuracy.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>A total of 807 K-ROAD participants (median age 72.0 years, 58.7% female) and 230 ADNI participants (median age 70.9 years, 49.1% female) were analyzed. Using a 95% sensitivity/specificity strategy, the low-risk group demonstrated NPVs of 94.7% (91.7%–97.7%, K-ROAD) and 99.0% (97.0%–100.0%, ADNI). The high-risk group showed PPVs of 97.6% (95.9%–99.3%, K-ROAD) and 98.8% (96.5%–100.0%, ADNI). Intermediate-risk groups comprised 33.3% (K-ROAD) and 20.9% (ADNI) of participants. Plasma p-tau217 testing in intermediate-risk groups yielded PPVs of 92.5% (88.7%–96.3%, K-ROAD) and 90.0% (79.0%–100.0%, ADNI) and NPVs of 83.1% (75.0%–91.2%, K-ROAD) and 83.3% (66.1%–100.0%, ADNI). The overall workflow accuracy was 94.2% (92.6%–95.8%, K-ROAD) and 96.5% (94.1%–98.9%, ADNI).</p></section><section id="sec4"><h3 class="pmc_sec_title">Discussion</h3>
<p>The 2-stage diagnostic workflow integrating MRI-based risk stratification and plasma p-tau217 testing accurately identified individuals with Aβ PET positivity in early-stage AD, substantially reducing the need for additional biomarker testing. However, the generalizability may be limited by modest incremental improvement over baseline models and limited racial and ethnic diversity.</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Alzheimer disease (AD) is characterized by 2 key pathologic hallmarks: extracellular β-amyloid (Aβ) plaques and intracellular tau neurofibrillary tangles.<sup><a href="#R1" class="usa-link" aria-describedby="R1">1,2</a></sup> These pathologies result in neurodegeneration, leading to regional brain atrophy observable in vivo through structural imaging.<sup><a href="#R2" class="usa-link" aria-describedby="R2">2-4</a></sup> Notable changes include atrophy in the medial temporal lobe<sup><a href="#R5" class="usa-link" aria-describedby="R5">5-7</a></sup> and posterior parietal cortex,<sup><a href="#R7" class="usa-link" aria-describedby="R7">7,8</a></sup> which often manifest as sulcal widening and ventricular enlargement, particularly in the temporal horns of the lateral ventricles (LVs).<sup><a href="#R9" class="usa-link" aria-describedby="R9">9</a></sup> Recently, Aβ-targeted therapies have shown promise in modifying the disease course in its early stages.<sup><a href="#R10" class="usa-link" aria-describedby="R10">10,11</a></sup> Consequently, detecting Aβ accumulation in vivo has become critical for identifying patients with mild cognitive impairment (MCI) or early Alzheimer-type dementia (ATD) who may benefit from these therapies.</p>
<p>Currently, Aβ accumulation is most reliably assessed using amyloid PET imaging<sup><a href="#R12" class="usa-link" aria-describedby="R12">12-14</a></sup> or CSF testing.<sup><a href="#R15" class="usa-link" aria-describedby="R15">15-17</a></sup> However, despite their high accuracy, these modalities are costly, invasive, and not universally accessible, limiting their utility in routine clinical practice.<sup><a href="#R18" class="usa-link" aria-describedby="R18">18,19</a></sup> By contrast, structural brain imaging such as MRI or CT is a mandatory diagnostic tool for evaluating patients with cognitive impairment because it is essential for excluding alternative causes such as brain tumors, strokes, or hydrocephalus.<sup><a href="#R20" class="usa-link" aria-describedby="R20">20,21</a></sup> MRI is generally preferred over CT in clinical practice because of its superior sensitivity to subtle atrophy and its ability to rule out multiple differential diagnoses with a single scan, although it cannot be performed in patients with contraindications. Moreover, MRI-derived brain atrophy patterns, including medial temporal atrophy and related structural changes, correlate significantly with Aβ accumulation.<sup><a href="#R22" class="usa-link" aria-describedby="R22">22-25</a></sup> This provides an opportunity to screen for Aβ positivity using existing imaging data, eliminating the need for additional costly or invasive procedures.</p>
<p>However, relying solely on MRI findings poses challenges, particularly in ambiguous cases where structural changes are subtle or overlap with non-AD conditions.<sup><a href="#R26" class="usa-link" aria-describedby="R26">26,27</a></sup> A gray zone remains, where Aβ positivity cannot be clearly classified based on MRI findings alone.<sup><a href="#R18" class="usa-link" aria-describedby="R18">18,28</a></sup> To address this uncertainty, a risk stratification framework is necessary, where MRI is used to identify low-risk and high-risk individuals while intermediate-risk individuals undergo confirmatory testing.<sup><a href="#R29" class="usa-link" aria-describedby="R29">29</a></sup> Plasma p-tau217, a biomarker reflective of tau-related neurodegeneration, has emerged as a highly accurate tool for detecting Aβ accumulation.<sup><a href="#R30" class="usa-link" aria-describedby="R30">30-33</a></sup> Its potential utility as a confirmatory test within a 2-stage workflow makes it an ideal complement to MRI, addressing diagnostic uncertainty in intermediate-risk cases.</p>
<p>In this study, we aim to evaluate a 2-stage diagnostic workflow integrating MRI-based brain atrophy assessments and plasma p-tau217 testing to predict Aβ PET positivity in patients with early-stage AD, with validation across different clinical cohorts to ensure broader applicability. By combining these modalities, the study seeks to address diagnostic uncertainty in intermediate-risk groups, optimize resource allocation, and provide a scalable framework for improving early diagnosis in clinical practice.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Participants</h3>
<p>This study was designed as a prospective cohort study conducted at a tertiary hospital in South Korea. Participants were recruited from the Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD) project in South Korea,<sup><a href="#R34" class="usa-link" aria-describedby="R34">34</a></sup> which is a global partner of the Alzheimer's Disease Neuroimaging Initiative (ADNI). This study used a convenience sampling approach. Individuals diagnosed with MCI and early-stage ATD, between 55 and 90 years, were included if they had undergone testing for APOE genotype, Aβ PET imaging, and 3D T1-weighted MRI. A comprehensive dementia assessment was conducted for all participants, including clinical interviews, detailed neurologic examinations, and standardized neuropsychological assessments using the Seoul Neuropsychological Screening Battery.<sup><a href="#R35" class="usa-link" aria-describedby="R35">35</a></sup> Especially, verbal memory was assessed using the Seoul Verbal Learning Test and visual memory using the Rey Complex Figure Test, including immediate recall, delayed recall, and recognition. MCI diagnosis was established using Petersen clinical criteria for amnestic MCI with the following modifications<sup><a href="#R36" class="usa-link" aria-describedby="R36">36,37</a></sup>: subjective memory concerns reported by the patient or caregiver, preserved functional independence in daily activities, objective cognitive performance falling below −1.0 SD of age-matched and education-matched norms in neuropsychological testing, and not being demented. The diagnosis of early-stage ATD was based on the 2011 National Institute on Aging and Alzheimer's Association criteria,<sup><a href="#R38" class="usa-link" aria-describedby="R38">38</a></sup> requiring a Clinical Dementia Rating (CDR) score of 0.5. Individuals with cognitive impairment due to secondary causes, as confirmed by laboratory tests for vitamin B12 deficiency; syphilis serology; and thyroid, renal, or hepatic dysfunction, were excluded. Participants with major structural brain lesions, such as territorial infarction, intracranial hemorrhage, brain tumors, or extensive white matter hyperintensities, classified according to the modified Fazekas ischemic scale,<sup><a href="#R39" class="usa-link" aria-describedby="R39">39</a></sup> were also excluded. Furthermore, those diagnosed with other neurodegenerative diseases, such as progressive supranuclear palsy, corticobasal syndrome, frontotemporal dementia, or dementia with Lewy body/Parkinson disease, were not included. To ensure high statistical power, all eligible participants who met the inclusion and exclusion criteria and had complete data for the required biomarkers were included in the study. A detailed participant selection process is illustrated in eFigure 1.</p>
<p>For replication, an external cohort was drawn from ADNI, a widely used, publicly available data set consisting mainly of non-Hispanic Whites, led by principal investigator Michael Weiner. Individuals with MCI and early-stage ATD with a CDR score of 0.5 and available plasma p-tau217 measurements were included in this study (eFigure 1). Detailed inclusion and exclusion criteria for ADNI participants can be accessed on the official ADNI website.<sup><a href="#R40" class="usa-link" aria-describedby="R40">40</a></sup></p></section><section id="s2-2"><h3 class="pmc_sec_title">Aβ PET Acquisition and Determination of Aβ Positivity</h3>
<p>Aβ PET scans were acquired using either 18F-florbetaben (FBB) or 18F-flutemetamol (FMM) tracer to assess amyloid deposition in the brain. Following ligand manufacturer-recommended guidelines, dynamic 20-minute PET imaging, consisting of four 5-minute frames, was performed 90 minutes after the injection of a mean dose of 311.5 MBq FBB or 185 MBq FMM. PET images were aligned with each participant's MRI scan and spatially normalized to the Montreal Neurological Institute-152 standard using the appropriate transformation matrix. The gray matter of the brain was segmented into 116 anatomical areas using the automated anatomical labeling atlas. Standardized uptake value ratios (SUVRs) were computed using the cerebellum as the reference region, with regional masks obtained from the Global Alzheimer's Association Interactive Network website.<sup><a href="#R41" class="usa-link" aria-describedby="R41">41</a></sup> Aβ burden was quantified using BeauBrain Amylo software, which implements image processing methodologies based on the Centiloid (CL) scale.</p>
<p>For ADNI participants, Aβ PET scans were acquired using 18F-florbetapir (FBP), with 20-minute dynamic acquisition (four 5-minute frames) occurring between 50 and 70 minutes after injection of 10.0 mCi of FBP. ADNI's standardized image pipeline included frame co-registration, motion correction, and intensity normalization to ensure data consistency across imaging sites. Full details of the T1 and PET acquisition parameters and image processing steps are listed on the ADNI website.<sup><a href="#R42" class="usa-link" aria-describedby="R42">42</a></sup> A previously validated transformation equation was applied to convert SUVR values to CL units. A threshold of 20 CL was used to define Aβ PET positivity across both K-ROAD and ADNI cohorts.<sup><a href="#R13" class="usa-link" aria-describedby="R13">13</a></sup> The assessment of the Aβ PET status was blinded to the participants' clinical information, MRI-based brain atrophy, and plasma p-tau217 result.</p></section><section id="s2-3"><h3 class="pmc_sec_title">Brain MRI Image Preprocessing</h3>
<p>In the K-ROAD cohort, high-resolution 3D T1 turbo field-echo MRI sequences were obtained using a 3.0T Philips Achieva scanner (Philips Healthcare, Andover, MA). Acquisition parameters included a sagittal slice thickness of 1.0 mm with 50% overlap and a reconstructed matrix size of 480 × 480 pixels over a 240-mm field of view. ADNI participants underwent structural MRI using 3.0T MRI scanners, with either inversion recovery–fast spoiled gradient-recalled or magnetization-prepared rapid gradient-echo sequences. Full details of the T1-weighted acquisition and processing protocols for ADNI are available on the official website.</p></section><section id="s2-4"><h3 class="pmc_sec_title">AI-Driven Brain Atrophy Assessment</h3>
<p><a href="#F1" class="usa-link">Figure 1</a> illustrates the framework used in this study. An AI-based brain MRI analysis was implemented using BeauBrain Morph software, which provides quantitative assessment of brain atrophy by segmenting CSF regions on MRI scans. A 2D nnUNet segmentation model<sup><a href="#R43" class="usa-link" aria-describedby="R43">43</a></sup> was used, and performance was evaluated using 5-fold cross-validation. Preprocessed images underwent further refinement with the default nnUNet preprocessing pipeline before training. The model was trained with a leaky rectified linear unit as the activation function, an objective function combining Dice loss and cross-entropy loss, and stochastic gradient descent as the optimizer. The learning rate was set to 1e-2, with a weight decay of 3e-5. Training was conducted over 200 epochs with a batch size of 64. In addition, to facilitate cross-cohort comparisons, we standardized regional brain volumes using W-scores, referencing cognitively unimpaired participants (n = 936; age range 65.0–76.0 years; 61.5% female) in the K-ROAD cohort, while accounting for age and sex differences. We prioritized CSF spaces for brain atrophy assessment because of their strong intensity contrast with adjacent tissues, which reduces vendor-related variability and enhances reproducibility. These measures align with regions commonly used in clinical visual assessments by radiologists and neurologists, improving their applicability. In addition, this approach facilitates the use of 2D T1 MRI and CT scans, making it more suitable for real-world diagnostic settings. The analysts were blinded to the participants' clinical information and Aβ PET status. This AI-driven method was chosen because of its high diagnostic precision, ability to accommodate data from multiple MRI vendors, and significant reduction of the time and potential for human error inherent in manual segmentation. The software program automatically identifies 14 specific CSF regions, including the left and right CSF areas of the frontal, occipital, parietal, and temporal lobes, as well as the anterior LVs, posterior LVs, and temporal horns of LVs adjacent to the hippocampus.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. Proposed Framework.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367417_WNL-2025-200353f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e905/12367417/8a297a8bc265/WNL-2025-200353f1.jpg" loading="lazy" height="233" width="677" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The framework illustrates the results of an AI-powered brain MRI analysis that assesses brain atrophy using quantitative information from MRI scans. The 2-step framework for Aβ PET status classification aims to minimize additional confirmatory tests while ensuring accurate patient stratification. In the first step, a random forest model incorporating <em>APOE</em> ε4 status and regional CSF volume predicts Aβ PET positivity, stratifying participants into 3 risk categories. In the second step, plasma p-tau217 testing is applied exclusively to the intermediate-risk group to refine predictions and facilitate risk-based decision making. *The classification of Aβ-positive and Aβ-negative cases is determined based on Aβ PET status. Aβ = β-amyloid; CU = cognitively unimpaired; LV = lateral ventricle; L/R = left and right; ROI = region of interest.</p></figcaption></figure></section><section id="s2-5"><h3 class="pmc_sec_title">Plasma Collection and Processing for p-Tau217 Analysis</h3>
<p>Blood samples from the K-ROAD cohort were collected from each participant in tubes containing 0.5M EDTA and mixed for 5 minutes. The samples were then centrifuged at 1,300<em>g</em> for 10 minutes to separate plasma, which was subsequently aliquoted into 5 or 10 vials, each containing 0.3 mL of plasma. These plasma samples were stored at −75°C, following the National Biobank of the Republic of Korea's guidelines for human biospecimen storage and registration. The frozen plasma samples were then transported under −70°C conditions to the Department of Psychiatry and Neurochemistry at the University of Gothenburg, where plasma p-tau217 concentrations were quantified using the commercial ALZpath p-Tau217 immunoassay on the Single-Molecule Array (SIMOA) HD-X instrument. This system, developed by Quanterix (Billerica, MA), uses a paramagnetic microbead-based sandwich ELISA approach. The laboratory personnel were blinded to the participants' clinical diagnoses and Aβ PET status. For the ADNI cohort, plasma samples were processed following their standardized protocol and plasma p-tau217 analysis was conducted using the same ALZpath p-Tau217 immunoassay on the SIMOA HD-X instrument. While both cohorts used the ALZpath assay on the SIMOA instrument, K-ROAD samples were analyzed at the University of Gothenburg, whereas ADNI samples were processed and analyzed by Quanterix.</p></section><section id="s2-6"><h3 class="pmc_sec_title">Development of a 2-Stage Workflow for Aβ Positivity Prediction</h3>
<p>To predict Aβ PET positivity, we developed a classifier using several machine learning models, such as support vector machine, logistic regression, and random forest model, with a base model (including only age, sex, and <em>APOE</em> ε4 status) and W-scores of regional CSF volume as predictors (<a href="#F1" class="usa-link">Figure 1</a>). This algorithm was selected because of its superior classification performance compared with other machine learning models, such as support vector machine and logistic regression (eFigure 2). Probabilities of Aβ positivity were calculated based on brain atrophy and APOE ε4 status, and a 2-stage diagnostic approach was established for risk stratification. In the first stage, participants were classified into low-risk, intermediate-risk, and high-risk groups based on brain atrophy model-derived probabilities of Aβ PET positivity. Thresholding strategies were defined using lower probability thresholds (90%, 95%, and 97.5% sensitivity [Se]) to minimize false negatives and higher probability thresholds (90%, 95%, and 97.5% specificity [Sp]) to reduce false positives. For example, thresholds were set to achieve 95% Se with 95% Sp for both MCI and ATD. For each thresholding strategy, the prevalence of Aβ PET negativity in the low-risk group and Aβ PET positivity in the high-risk group was calculated. In the second stage, additional Aβ biomarker testing with plasma p-tau217 measurements was simulated exclusively for intermediate-risk participants identified in the first step. Plasma p-tau217 was used to refine Aβ PET predictions in this subgroup, and the concordance between plasma biomarker levels and Aβ PET status was assessed. The workflow's overall accuracy was calculated as the proportion of correct Aβ PET classifications across both stages, and the reduction in additional Aβ biomarker testing requirements was quantified to assess efficiency.</p></section><section id="s2-7"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>All statistical analyses were performed using R statistical software, version 4.0.2.<sup><a href="#R44" class="usa-link" aria-describedby="R44">44</a></sup> Descriptive statistics were computed for demographic and clinical characteristics, summarizing variables across participants. Group differences in continuous variables were assessed using analysis of variance, followed by Tukey post hoc comparisons when applicable. For categorical variables, χ<sup>2</sup> tests were performed to assess group differences, with Bonferroni correction applied for multiple pairwise comparisons where necessary. Predictive modeling was performed using Python version 3.8, with libraries such as scikit-learn<sup><a href="#R45" class="usa-link" aria-describedby="R45">45</a></sup> for machine learning tasks. The random forest classifier was trained and validated using k-fold cross-validation (k = 5). For each fold, the model was trained on a subset of the data (training set) and its predictive performance was evaluated on the held-out test set, repeated across all 5 folds. Performance metrics, including accuracy, positive predictive value (PPV), and negative predictive value (NPV), were used to assess model effectiveness. To optimize hyperparameters, a grid search approach was used, fine-tuning key parameters such <em>n_estimators</em>, <em>max_depth</em>, <em>min_samples_split</em>, <em>min_samples_leaf</em>, and <em>max_features</em>. In addition, a backward elimination approach was used to evaluate whether a base model (including only age, sex, and <em>APOE</em> ε4 status) would provide preferable predictive performances to the full model (including only age, sex, and <em>APOE</em> ε4 status and MRI measures). To maintain consistency throughout the predictive analysis, the same modeling approach was applied across all modeling-building processes. Thresholds for stratifying participants into risk groups were determined based on the desired Se and Sp levels (90%, 95%, and 97.5%). Plasma p-tau217 results were incorporated in the intermediate-risk group, and the concordance between plasma biomarker results and Aβ PET status was evaluated. The overall accuracy of the 2-stage diagnostic workflow was calculated, and statistical significance was determined at a 2-tailed alpha level of 0.05.</p></section><section id="s2-8"><h3 class="pmc_sec_title">Standard Protocol Approvals, Registrations, and Participant Consents</h3>
<p>This study was approved by the Institutional Review Board of Samsung Medical Center, and written informed consent was obtained from all participants and their caregivers in accordance with the Declaration of Helsinki. In addition, the use and publication of ADNI data were approved by the ADNI Data Sharing and Publications Committee.</p></section><section id="s2-9"><h3 class="pmc_sec_title">Data Availability</h3>
<p>The data sets generated and analyzed during this study are available from the corresponding author on reasonable request.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">Participant Characteristics</h3>
<p>The K-ROAD cohort included 807 participants with a median age of 72.0 years (58.7% female and 46.6% of <em>APOE</em> ε4 carriers) (<a href="#T1" class="usa-link">Table 1</a>). Aβ PET positivity was observed in 64.3% of participants, and the median CDR-Sum of Boxes (CDR-SOB) score was 1.5. The median interval between the MRI scan and Aβ PET imaging was 83.0 days (interquartile range [IQR] 23.0–163.5), and the median interval between the MRI scan and plasma p-tau217 measurement was 102.5 days (IQR 29.0–223.5). In addition, the independent set from ADNI included 230 participants with a median age of 70.9 years (49.1% female and 34.8% of <em>APOE</em> ε4 carriers) (<a href="#T1" class="usa-link">Table 1</a>). Aβ PET positivity was observed in 52.6% of participants, with a median CDR-SOB score of 1.0.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographics of Study Participants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">K-ROAD (n = 807)</td>
<td rowspan="1" colspan="1">ADNI (n = 230)</td>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Diagnosis, MCI, n (%)</td>
<td rowspan="1" colspan="1">671 (83.2)</td>
<td rowspan="1" colspan="1">212 (92.2)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age, y</td>
<td rowspan="1" colspan="1">72.0 (65.0–78.0)</td>
<td rowspan="1" colspan="1">70.9 (66.6–75.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sex, female, n (%)</td>
<td rowspan="1" colspan="1">474 (58.7)</td>
<td rowspan="1" colspan="1">113 (49.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Race/ethnicity, n (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Asian</td>
<td rowspan="1" colspan="1">807 (100.0)</td>
<td rowspan="1" colspan="1">3 (1.3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Non-Hispanic White</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">205 (89.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Hispanic or Latino</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">22 (9.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Education, y</td>
<td rowspan="1" colspan="1">12.0 (9.0–16.0)</td>
<td rowspan="1" colspan="1">16.0 (14.0–18.0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<em>APOE</em> ε4 carriers, n (%)</td>
<td rowspan="1" colspan="1">376 (46.6)</td>
<td rowspan="1" colspan="1">80 (34.8)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Aβ PET positive, n (%)</td>
<td rowspan="1" colspan="1">519 (64.3)</td>
<td rowspan="1" colspan="1">121 (52.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Plasma p-tau217, pg/mL<sup><a href="#tblfn1" class="usa-link">a</a></sup>
</td>
<td rowspan="1" colspan="1">0.73 (0.30–1.2)</td>
<td rowspan="1" colspan="1">0.43 (0.2–0.7)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">CDR-SOB</td>
<td rowspan="1" colspan="1">1.5 (1.0–3.0)</td>
<td rowspan="1" colspan="1">1.0 (0.5–2.0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn6"><p>Abbreviations: Aβ = amyloid-β; ADNI = Alzheimer's Disease Neuroimaging Initiative; CDR-SOB = Clinical Dementia Rating–Sum of Boxes; K-ROAD = Korea-Registries to Overcome Dementia and Accelerate Dementia Research; MCI = mild cognitive impairment; SIMOA = Single-Molecule Array.</p></div>
<div class="fn" id="fn7"><p>Data are presented as n (%) for categorical variables and median with interquartile range for continuous variables.</p></div>
<div class="fn" id="fn8"><p>Statistical significance was defined as <em>p</em> &lt; 0.05.</p></div>
<div class="fn" id="tblfn1">
<sup>a</sup><p class="display-inline">Plasma p-tau217 levels were measured using the same SIMOA platform and ALZpath assay, but the differences between the cohorts may reflect site-specific variability (K-ROAD measurements were conducted at the University of Gothenburg and ADNI measurements at Quanterix).</p>
</div>
</div></section></section><section id="s3-2"><h3 class="pmc_sec_title">First-Stage Risk Stratification Using MRI-Based Brain Atrophy Patterns</h3>
<p>MRI-based brain atrophy patterns were used in the first stage of a 2-stage diagnostic workflow to stratify participants into low-risk, intermediate-risk, and high-risk groups based on predicted probabilities of Aβ PET positivity in K-ROAD (<a href="#F2" class="usa-link">Figure 2A</a>) and ADNI (<a href="#F2" class="usa-link">Figure 2B</a>) cohorts. The random forest model was selected because of its superior classification performance compared with other machine learning models (eFigure 2). Using both K-ROAD and ADNI data sets, adding MRI features to the base model (age + sex + APOE ε4) improved area under the curve (AUC) from 0.76 to 0.81 (<em>p</em> = 0.009) in the K-ROAD cohort and from 0.75 to 0.78 (<em>p</em> = 0.13) in the ADNI cohort (eTable 1).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Distribution and Thresholds of Probability of Aβ (+) Based on MRI-Derived Brain Atrophy Patterns for the K-ROAD Cohort (A) and for the ADNI Cohort (B).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367417_WNL-2025-200353f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e905/12367417/8af10d69da10/WNL-2025-200353f2.jpg" loading="lazy" height="259" width="772" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Blue dots represent Aβ PET–negative patients while red dots indicate Aβ PET–positive patients. The right y-axis indicates probability values aligned with evaluated 3 risk thresholds, accompanied by metrics defining Se (90%, 95%, 97.5%) and Sp (90%, 95%, 97.5%). Aβ = β-amyloid; ADNI = Alzheimer's Disease Neuroimaging Initiative; K-ROAD = Korea-Registries to Overcome Dementia and Accelerate Dementia Research; Se = sensitivity; Sp = specificity.</p></figcaption></figure><p>In the K-ROAD cohort, for Se/Sp levels of 90%, 95%, and 97.5%, the NPVs in the low-risk group were 93.6%, 94.7%, and 96.3%, respectively, while the PPVs in the high-risk group were 93.3%, 97.6%, and 98.3%, respectively (<a href="#T2" class="usa-link">Table 2</a>). The proportion of patients categorized into the intermediate-risk group was 32.6%, 33.3%, and 46.7%, respectively. Among these, the Se/Sp level of 95% seemed most suitable, balancing high predictive values and a manageable size of the intermediate-risk group, which in turn helps reduce the overall cost of further testing (<a href="#F3" class="usa-link">Figure 3</a>). In the ADNI cohort, for Se/Sp levels of 90%, 95%, and 97.5%, the NPVs were 97.1%, 99.0%, and 100.0%, respectively, and the PPVs were 95.3%, 98.8%, and 98.8%, respectively (<a href="#T2" class="usa-link">Table 2</a>). The intermediate-risk group sizes were 8.7%, 20.9%, and 25.6%, with 95% Se/Sp offering the best balance of accuracy and group size. Detailed demographic information for each of the 3 risk groups classified using the 95% Se/Sp strategy is provided in eTable 2. Because the model demonstrated good validation and calibration, probability thresholds were separately derived for the K-ROAD and ADNI data sets (eFigure 3).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Accuracy and Risk Stratification for Aβ PET Positivity Across Threshold Strategies in K-ROAD and ADNI Cohorts</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<td rowspan="3" colspan="1">Risk groups</td>
<td colspan="3" rowspan="1">K-ROAD</td>
<td colspan="3" rowspan="1">ADNI</td>
</tr>
<tr>
<td rowspan="2" colspan="1">Participants in risk group, n (%)</td>
<td colspan="2" rowspan="1">Aβ PET status</td>
<td rowspan="2" colspan="1">Participants in risk group, n (%)</td>
<td colspan="2" rowspan="1">Aβ PET status</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Negativity, n (%)</td>
<td rowspan="1" colspan="1">Positivity, n (%)</td>
<td rowspan="1" colspan="1">Negativity, n (%)</td>
<td rowspan="1" colspan="1">Positivity, n (%)</td>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">90% Se lower risk threshold/90% Sp higher risk threshold</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Low risk</td>
<td rowspan="1" colspan="1">218 (27.0)</td>
<td rowspan="1" colspan="1">204 (93.6)</td>
<td rowspan="1" colspan="1">14 (6.4)</td>
<td rowspan="1" colspan="1">103 (44.8)</td>
<td rowspan="1" colspan="1">100 (97.1)</td>
<td rowspan="1" colspan="1">3 (29)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Intermediate risk</td>
<td rowspan="1" colspan="1">188 (23.3)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">20 (8.7)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> High risk</td>
<td rowspan="1" colspan="1">401 (49.7)</td>
<td rowspan="1" colspan="1">27 (6.7)</td>
<td rowspan="1" colspan="1">374 (93.3)</td>
<td rowspan="1" colspan="1">107 (46.5)</td>
<td rowspan="1" colspan="1">5 (4.7)</td>
<td rowspan="1" colspan="1">102 (95.3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">95% Se lower risk threshold/95% Sp higher risk threshold</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Low risk</td>
<td rowspan="1" colspan="1">208 (25.8)</td>
<td rowspan="1" colspan="1">197 (94.7)</td>
<td rowspan="1" colspan="1">11 (5.3)</td>
<td rowspan="1" colspan="1">97 (42.2)</td>
<td rowspan="1" colspan="1">96 (99.0)</td>
<td rowspan="1" colspan="1">1 (1.0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Intermediate risk</td>
<td rowspan="1" colspan="1">269 (33.3)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">48 (20.9)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> High risk</td>
<td rowspan="1" colspan="1">330 (40.9)</td>
<td rowspan="1" colspan="1">8 (2.4)</td>
<td rowspan="1" colspan="1">322 (97.6)</td>
<td rowspan="1" colspan="1">85 (37.0)</td>
<td rowspan="1" colspan="1">1 (1.2)</td>
<td rowspan="1" colspan="1">84 (98.8)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">97.5% Se lower risk threshold/97.5% Sp higher risk threshold</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Low risk</td>
<td rowspan="1" colspan="1">136 (16.9)</td>
<td rowspan="1" colspan="1">131 (96.3)</td>
<td rowspan="1" colspan="1">5 (3.7)</td>
<td rowspan="1" colspan="1">87 (37.8)</td>
<td rowspan="1" colspan="1">87 (100)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Intermediate risk</td>
<td rowspan="1" colspan="1">377 (46.7)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">59 (25.7)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> High risk</td>
<td rowspan="1" colspan="1">294 (36.4)</td>
<td rowspan="1" colspan="1">5 (1.7)</td>
<td rowspan="1" colspan="1">289 (98.3)</td>
<td rowspan="1" colspan="1">84 (36.5)</td>
<td rowspan="1" colspan="1">1 (1.2)</td>
<td rowspan="1" colspan="1">83 (98.8)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn10"><p>Abbreviations: Aβ = amyloid-β; ADNI = Alzheimer's Disease Neuroimaging Initiative; K-ROAD = Korea-Registries to Overcome Dementia and Accelerate Dementia Research; NPV = negative predictive value; PPV = positive predictive value; Se = sensitivity; Sp = specificity.</p></div>
<div class="fn" id="fn11"><p>Data are presented as n or n (%). The first column indicates each of the evaluated strategies for MRI-based risk stratification, along with the corresponding low-risk, intermediate-risk, and high-risk groups for each strategy. The second column indicates the number of screened individuals assigned to each risk category, with the percentage of individuals in the intermediate-risk group shown in parentheses. The third and fourth columns indicate the Aβ PET status for low-risk, intermediate-risk, and high-risk groups. The percentage of Aβ-negative individuals in the low-risk group and the percentage of Aβ-positive individuals in the high-risk group correspond to the NPV and PPV, respectively, for each threshold strategy. The subsequent columns follow the same structure for the ADNI cohort.</p></div>
</div></section><figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Overall Workflow Accuracy and Cost-Based Approach.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367417_WNL-2025-200353f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e905/12367417/442635bf538e/WNL-2025-200353f3.jpg" loading="lazy" height="212" width="675" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) The overall accuracy of the 2-step workflow, reflecting the proportion of correct classifications in both low-risk and high-risk groups, along with the accuracy of plasma p-tau217 classifications for the intermediate-risk group, was calculated for the K-ROAD cohort. The error bars correspond to 95% CIs. (B) Bar plots indicating the percentage of the intermediate-risk group by applying the risk stratification strategy, based on each of the risk threshold strategies. (C) The cost estimation for each risk threshold strategy was determined by incorporating additional expenses associated with the plasma p-tau217 test, which was used to assess Aβ PET positivity within the intermediate group. Aβ = β-amyloid; K-ROAD = Korea-Registries to Overcome Dementia and Accelerate Dementia Research.</p></figcaption></figure></section><section id="s3-3"><h3 class="pmc_sec_title">Second-Stage Refinement of Aβ PET Status Prediction With Plasma p-Tau217 Testing</h3>
<p>In the second stage of the workflow, plasma p-tau217 testing was used to refine Aβ PET status predictions for participants classified as intermediate risk based on the MRI-based model (<a href="#F4" class="usa-link">Figure 4</a>). Using the 95% Se/Sp strategy, which was identified as optimal in the first stage, 33.3% of K-ROAD participants were classified into the intermediate-risk group. Plasma p-tau217 testing achieved a PPV of 92.5% and a NPV of 83.1%, effectively improving diagnostic accuracy for these uncertain cases. The 95% Se/Sp strategy also achieved the highest accuracy at 94.2% (95% CI 92.6%–95.8%) while reducing additional testing by 66.7% (<a href="#F4" class="usa-link">Figure 4A</a>). A sex-stratified analysis showed that the overall accuracy of the 2-stage workflow was comparable between men (93.7%) and women (94.5%). The proportion of participants classified as intermediate risk was also similar (36.9% in men, 30.8% in women), suggesting consistent performance across sexes (eFigure 4). In the ADNI cohort, 20.9% of participants were classified into the intermediate-risk group under the same 95% Se/Sp strategy. Plasma p-tau217 testing demonstrated a PPV of 90.0% for Aβ PET positivity and an NPV of 83.3%, confirming the robustness and scalability of the 2-stage diagnostic workflow (<a href="#F4" class="usa-link">Figure 4B</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4. Two-Stage Diagnostic Workflow for Aβ (+) on PET Prediction Integrating MRI-Based Risk Stratification and Plasma p-Tau217 Testing in K-ROAD (A) and ADNI (B) Cohorts.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367417_WNL-2025-200353f4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e905/12367417/c85bfb968e81/WNL-2025-200353f4.jpg" loading="lazy" height="339" width="674" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The 2-stage diagnostic workflow, based on the 95% Se and 95% Sp threshold strategies, is summarized for the K-ROAD (A) and ANDI (B) cohorts. On the right, the results of the first step, MRI-based risk stratification, are displayed, with red, yellow, and blue dots representing individuals in the high-risk, intermediate-risk, and low-risk groups, respectively. The percentage of Aβ PET positivity in the high-risk group and the percentage of Aβ PET negativity in the low-risk group are shown, reflecting the predictive accuracy of Aβ PET status. To the left, the results of the second step, plasma p-tau217 testing conducted exclusively for the intermediate-risk group, are presented. The predictive accuracy for Aβ PET status is represented using the NPV and PPV. Aβ = amyloid-β; ADNI = Alzheimer's Disease Neuroimaging Initiative; K-ROAD = Korea-Registries to Overcome Dementia and Accelerate Dementia Research; NPV = negative predictive value; PPV = positive predictive value; Se = sensitivity; Sp = specificity.</p></figcaption></figure><p>We quantitatively assessed the incremental value of second-stage testing. In both K-ROAD and ADNI cohorts, the 2-step workflow significantly outperformed the 1-step model (K-ROAD AUC: 0.93 vs 0.82; ADNI AUC: 0.92 vs 0.80; DeLong test, <em>p</em> &lt; 0.001 for both; <a href="#F5" class="usa-link">Figure 5, A and B</a>). In the intermediate-risk subgroup, the 2-step approach also significantly improved PPV and NPV (McNemar test, <em>p</em> &lt; 0.01; <a href="#F5" class="usa-link">Figure 5C</a>).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5. Model Performance and Predictive Value Across Classification Strategies.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367417_WNL-2025-200353f5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e905/12367417/13fa9a5ee7c5/WNL-2025-200353f5.jpg" loading="lazy" height="243" width="677" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>ROC curves in the K-ROAD cohort (A) and in the ADNI cohort (B) comparing the 1-step (MRI-only) model and the proposed 2-step model. (C) Comparison of PPV and NPV between the 1-step (MRI-only) and 2-step models in the intermediate-risk group across cohorts. ADNI = Alzheimer's Disease Neuroimaging Initiative; K-ROAD = Korea-Registries to Overcome Dementia and Accelerate Dementia Research; NPV = negative predictive value; PPV = positive predictive value; ROC = receiver operating characteristic.</p></figcaption></figure></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>This study used a 2-stage diagnostic workflow combining MRI-based brain atrophy assessments and plasma p-tau217 measurements to stratify individuals with early-stage AD into low-risk, intermediate-risk, and high-risk groups for Aβ PET positivity. Our major findings were as follows. First, MRI-based risk stratification effectively identified individuals at low and high risk of Aβ PET positivity, demonstrating its reliability. Second, plasma p-tau217 testing further refined predictions within the intermediate-risk group, addressing diagnostic uncertainty and enhancing workflow accuracy. Finally, the 2-stage diagnostic workflow, validated using both K-ROAD and ADNI cohorts, highlighted the potential of leveraging routinely collected MRI data to reduce the need for additional biomarker testing, optimizing resource allocation in clinical practice.</p>
<p>Our first finding showed that MRI-based risk stratification effectively identified Aβ PET–negative individuals in the low-risk group and Aβ PET–positive individuals in the high-risk group, demonstrating its reliability in accurately classifying individuals at both ends of the risk spectrum. This approach was validated in the ADNI cohort, further supporting its generalizability across diverse clinical settings. Regional brain atrophy, particularly in areas such as the medial temporal lobe, parietal cortex, and precuneus, has been shown to correlate strongly with Aβ-related neurodegeneration.<sup><a href="#R46" class="usa-link" aria-describedby="R46">46</a></sup> Based on these findings, previous studies have explored MRI-derived structural changes for binary classification of Aβ PET status.<sup><a href="#R24" class="usa-link" aria-describedby="R24">24,47</a></sup> However, these approaches often fail to address diagnostic uncertainty in intermediate cases, where structural changes may be less distinct.<sup><a href="#R48" class="usa-link" aria-describedby="R48">48,49</a></sup> Our study's unique contribution lies in its probabilistic framework, which categorizes individuals into distinct risk groups, providing a more nuanced and targeted strategy for resolving diagnostic ambiguity and guiding confirmatory testing or clinical monitoring.</p>
<p>While <em>APOE</em> ε4 status was one of the input variables for risk stratification, the observed differences in APOE distribution across risk groups are not solely an artifact of model design but reflect a meaningful biological association. <em>APOE</em> ε is a well-established genetic risk factor of amyloid accumulation, and its alignment with risk group classification supports the validity of our approach. Additional analyses confirmed that APOE status independently contributes to risk stratification beyond its role as a predictor, reinforcing the robustness of our model (eTable 3).</p>
<p>Our second major finding demonstrated that plasma p-tau217 testing improved predictions within the intermediate-risk group, effectively resolving diagnostic uncertainty and enhancing overall workflow accuracy. This finding was replicated in the ADNI cohort, confirming the utility of plasma p-tau217 as a complementary biomarker for refining risk stratification across diverse clinical setting. Previous studies have demonstrated that plasma p-tau217 is highly accurate for predicting Aβ PET status across entire cohorts, with consistently high concordance rates observed in diverse populations.<sup><a href="#R30" class="usa-link" aria-describedby="R30">30,50,51</a></sup> However, our findings highlight its robust predictive performance specifically in cases with the greatest diagnostic uncertainty, such as those in the intermediate-risk group. This result emphasizes the biomarker's value in a risk stratification framework, where resolving ambiguity in intermediate-risk groups is critical. By capturing biochemical changes associated with Aβ pathology, plasma p-tau217 complements MRI-derived structural data, enhancing the workflow's overall precision. This integration provides a scalable and efficient approach to optimizing diagnostic accuracy and resource allocation in clinical practice. Although sex differences have been reported in AD pathology, our sex-stratified analysis demonstrated that the diagnostic accuracy and intermediate-risk proportions were comparable between male and female participants. This finding supports the applicability of our workflow across sexes.</p>
<p>Our final major finding was that leveraging MRI data already collected as part of routine diagnostic evaluations for cognitive impairment significantly reduced the need for additional biomarker testing. To illustrate potential cost savings, we compared our 2-stage workflow with universal PET screening. With amyloid PET positivity rates of 64.3% (K-ROAD) and 52.6% (ADNI), recruiting 1,000 amyloid-positive participants using universal PET would cost approximately USD 6.22 million and USD 7.61 million, respectively (at USD 4,000 per PET scan). By contrast, our workflow reserved PET testing only for the intermediate-risk group identified by MRI-based stratification (33.3% in K-ROAD; 20.9% in ADNI), who underwent plasma p-tau217 testing at an estimated global market price of USD 300 per test. This significantly reduced additional biomarker testing costs (USD 156,300 in K-ROAD; USD 125,100 in ADNI) while achieving overall accuracies of 94.2% (K-ROAD) and 96.5% (ADNI)—comparable to the performance standards (∼90%) recommended by the CEO Initiative. These results highlight the clinical value of optimizing resource allocation by using MRI, a routine diagnostic tool, to efficiently stratify risk and prioritize biomarker testing for diagnostically uncertain cases. With the increasing availability of amyloid-targeted therapies, identifying amyloid-positive individuals has become essential in early-stage AD management. Our MRI-driven workflow reduces reliance on costly and invasive PET imaging, ensuring that resources are focused effectively on patients most likely to benefit.</p>
<p>A major methodological strength of our study lies in its 2-stage diagnostic workflow, which combines MRI-based risk stratification with plasma biomarker testing to improve diagnostic precision and reduce unnecessary testing in a scalable and clinically practical manner. The two-step approach has traditionally been applied in very low-prevalence conditions, such as HIV screening. More recently, this design has been recognized as an effective strategy to optimize diagnostic precision and resource allocation by reducing unnecessary testing.<sup><a href="#R52" class="usa-link" aria-describedby="R52">52</a></sup> However, several limitations should be noted. First, although our 2-stage approach significantly improved diagnostic accuracy, the incremental improvement compared with the baseline model was modest, somewhat limiting the clinical impact of our findings. Nevertheless, even modest improvements can be valuable in clinical practice, particularly given the importance of accurate amyloid detection for patient management and therapeutic decision making. Second, while plasma p-tau217 biomarkers have shown high diagnostic accuracy, the lack of a clear bimodal distribution can lead to overlap between Alzheimer and non-Alzheimer conditions.<sup><a href="#R53" class="usa-link" aria-describedby="R53">53,54</a></sup> However, our study demonstrated high accuracy of plasma p-tau217 within the intermediate-risk group, mitigating concerns about its diagnostic overlap. Third, the brain atrophy patterns observed in our participants are not entirely specific to AD and can also be seen in other neurodegenerative conditions such as limbic-predominant age-related TDP-43 encephalopathy or hippocampal sclerosis.<sup><a href="#R26" class="usa-link" aria-describedby="R26">26,27,55</a></sup> Finally, the generalizability of our findings may be limited by the lack of racial and ethnic diversity, as the K-ROAD participants consisted entirely of Korean individuals, and the ADNI participants were predominantly non-Hispanic White. Moreover, the unexpectedly low APOE ε4 carrier rate observed in the ADNI cohort may reflect sampling bias or specific inclusion criteria, further limiting generalizability. Future studies incorporating more ethnically diverse populations are needed to validate the applicability of our 2-stage diagnostic workflow across different racial and ethnic groups. Despite these limitations, our study provides valuable insights into the integration of neuroimaging and plasma biomarkers for AD risk stratification. By addressing diagnostic uncertainty in intermediate-risk cases and optimizing resource allocation, the proposed workflow offers a robust framework for improving early diagnosis and advancing clinical care in AD.</p>
<p>In conclusion, this study demonstrates the effectiveness of combining MRI-based risk stratification with plasma biomarker testing to address diagnostic uncertainty and enhance early detection of AD. By leveraging routinely collected imaging data and targeted biomarker testing, this workflow has the potential to improving diagnostic pathways and guiding clinical decision making for patients with early-stage AD.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Glossary</h2>
<dl class="def-list">
<dt id="G1">Aβ</dt>
<dd><p>β-amyloid</p></dd>
<dt id="G2">AD</dt>
<dd><p>Alzheimer disease</p></dd>
<dt id="G3">ADNI</dt>
<dd><p>Alzheimer's Disease Neuroimaging Initiative</p></dd>
<dt id="G4">ATD</dt>
<dd><p>Alzheimer-type dementia</p></dd>
<dt id="G5">AUC</dt>
<dd><p>area under the curve</p></dd>
<dt id="G6">CDR</dt>
<dd><p>Clinical Dementia Rating</p></dd>
<dt id="G7">CDR-SOB</dt>
<dd><p>CDR-Sum of Boxes</p></dd>
<dt id="G8">CL</dt>
<dd><p>Centiloid</p></dd>
<dt id="G9">FBB</dt>
<dd><p>18F-florbetaben</p></dd>
<dt id="G10">FBP</dt>
<dd><p>18F-florbetapir</p></dd>
<dt id="G11">FMM</dt>
<dd><p>18F-flutemetamol</p></dd>
<dt id="G12">IQR</dt>
<dd><p>interquartile range</p></dd>
<dt id="G13">K-ROAD</dt>
<dd><p>Korea-Registries to Overcome Dementia and Accelerate Dementia Research</p></dd>
<dt id="G14">LV</dt>
<dd><p>lateral ventricle</p></dd>
<dt id="G15">MCI</dt>
<dd><p>mild cognitive impairment</p></dd>
<dt id="G16">NPV</dt>
<dd><p>negative predictive value</p></dd>
<dt id="G17">PPV</dt>
<dd><p>positive predictive value</p></dd>
<dt id="G18">Se</dt>
<dd><p>sensitivity</p></dd>
<dt id="G19">SIMOA</dt>
<dd><p>Single-Molecule Array</p></dd>
<dt id="G20">Sp</dt>
<dd><p>specificity</p></dd>
<dt id="G21">SUVR</dt>
<dd><p>standardized uptake value ratio</p></dd>
</dl></section><section id="A1" class="app"><h2 class="pmc_sec_title">Appendix 1. K-ROAD Coinvestigators</h2>
<section class="tw xbox font-sm" id="TU1"><div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1">Coinvestigators are listed at <a href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000213954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Neurology.org</a>.</td></tr></tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TU1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="A2" class="app"><h2 class="pmc_sec_title">Appendix 2. ADNI Coinvestigators</h2>
<section class="tw xbox font-sm" id="TU2"><div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1">Coinvestigators are listed at <a href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000213954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Neurology.org</a>.</td></tr></tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TU2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec21"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>S. Yim: drafting/revision of the manuscript for content, including medical writing for content; analysis or interpretation of data. S. Park: analysis or interpretation of data. K. Lim: major role in the acquisition of data. H. Kang: major role in the acquisition of data. D. Shin: major role in the acquisition of data. Hyunjin Jo: major role in the acquisition of data. H. Jang: major role in the acquisition of data. M.W. Weiner: analysis or interpretation of data. H. Zetterberg: analysis or interpretation of data. K. Blennow: analysis or interpretation of data. F. Gonzalez-Ortiz: analysis or interpretation of data. N.J. Ashton: analysis or interpretation of data. S.H. Kang: major role in the acquisition of data. J. Yun: major role in the acquisition of data. M.Y. Chun: major role in the acquisition of data. E-J Kim: major role in the acquisition of data. H.J. Kim: major role in the acquisition of data. D.L. Na: major role in the acquisition of data. J.P. Kim: major role in the acquisition of data. S.W. Seo: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; study concept or design; analysis or interpretation of data. K. Kwak: drafting/revision of the manuscript for content, including medical writing for content; study concept or design; analysis or interpretation of data.</p></section><section id="sec22"><h2 class="pmc_sec_title">Study Funding</h2>
<p>This research was supported by a grant of the Korea Dementia Research Project through the Korea Dementia Research Center (KDRC), funded by the Ministry of Health &amp; Welfare and the Ministry of Science and ICT, Republic of Korea (RS-2020-KH106434); by the Korea Health Technology R&amp;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &amp; Welfare, Republic of Korea (RS-2025-02223212); by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (RS-2019-NR040057); by the Institute of Information &amp; Communications Technology Planning &amp; Evaluation (IITP) grant funded by the Korea government (MSIT) (RS-2021-II212068, Artificial Intelligence Innovation Hub); by the Future Medicine 20*30 Project of Samsung Medical Center (SMX1250081); and by the Korea National Institute of Health research project (2024-ER1003-01). HZ is a Wallenberg Scholar and a Distinguished Professor at the Swedish Research Council supported by grants from the Swedish Research Council (2023-00356, 2022-01018, and 2019–02397); the European Union's Horizon Europe research and innovation programme under grant agreement No. 101053962; Swedish State Support for Clinical Research (ALFGBG-71320); the Alzheimer Drug Discovery Foundation (ADDF), USA (201809-2016862); the AD Strategic Fund and the Alzheimer's Association (ADSF-21-831376-C, ADSF-21-831381-C, ADSF-21-831377-C, and ADSF-24-1284328-C); and the European Partnership on Metrology, co-financed from the European Union's Horizon Europe Research and Innovation Programme, and by the Participating States (NEuroBioStand, 22HLT07); the Bluefield Project; Cure Alzheimer's Fund; the Olav Thon Foundation; the Erling-Persson Family Foundation; Familjen Rönströms Stiftelse, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden (FO2022-0270); the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 860197 (MIRIADE); the European Union Joint Programme – Neurodegenerative Disease Research (JPND2021-00694); the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre; the UK Dementia Research Institute at UCL (UKDRI-1003); and an anonymous donor.</p></section><section id="sec23"><h2 class="pmc_sec_title">Disclosure</h2>
<p>S.W. Seo is a co-founder of BeauBrain Healthcare Inc. S. Park, K. Lim, and K. Kwak were employed by BeauBrain Healthcare Inc. H. Zetterberg has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Enigma, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave; has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). All other authors report no disclosures relevant to the manuscript. Go to <a href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000213954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Neurology.org/N</a> for full disclosures.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease. Lancet. 2016;388(10043):505-517. doi: 10.1016/S0140-6736(15)01124-1
</cite> [<a href="https://doi.org/10.1016/S0140-6736(15)01124-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26921134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Alzheimer's%20disease&amp;volume=388&amp;issue=10043&amp;publication_year=2016&amp;pages=505-517&amp;pmid=26921134&amp;doi=10.1016/S0140-6736(15)01124-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Bloom GS. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505-508. doi: 10.1001/jamaneurol.2013.5847
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2013.5847" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24493463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Neurol&amp;title=Amyloid-beta%20and%20tau:%20the%20trigger%20and%20bullet%20in%20Alzheimer%20disease%20pathogenesis&amp;volume=71&amp;issue=4&amp;publication_year=2014&amp;pages=505-508&amp;pmid=24493463&amp;doi=10.1001/jamaneurol.2013.5847&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Wang L, Benzinger TL, Su Y, et al. Evaluation of tau imaging in staging alzheimer disease and revealing interactions between beta-amyloid and tauopathy. JAMA Neurol. 2016;73(9):1070-1077. doi: 10.1001/jamaneurol.2016.2078
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2016.2078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5237382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27454922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Neurol&amp;title=Evaluation%20of%20tau%20imaging%20in%20staging%20alzheimer%20disease%20and%20revealing%20interactions%20between%20beta-amyloid%20and%20tauopathy&amp;volume=73&amp;issue=9&amp;publication_year=2016&amp;pages=1070-1077&amp;pmid=27454922&amp;doi=10.1001/jamaneurol.2016.2078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Zhang H, Wei W, Zhao M, et al. Interaction between Aβ and tau in the pathogenesis of Alzheimer's disease. Int J Biol Sci. 2021;17(9):2181-2192. doi: 10.7150/ijbs.57078
</cite> [<a href="https://doi.org/10.7150/ijbs.57078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8241728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34239348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Biol%20Sci&amp;title=Interaction%20between%20A%CE%B2%20and%20tau%20in%20the%20pathogenesis%20of%20Alzheimer's%20disease&amp;volume=17&amp;issue=9&amp;publication_year=2021&amp;pages=2181-2192&amp;pmid=34239348&amp;doi=10.7150/ijbs.57078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Jarholm JA, Bjørnerud A, Dalaker TO, et al. Medial temporal lobe atrophy in predementia Alzheimer's disease: a longitudinal multi-site study comparing staging and A/T/N in a clinical research cohort. J Alzheimers Dis. 2023;94(1):259-279. doi: 10.3233/JAD-221274
</cite> [<a href="https://doi.org/10.3233/JAD-221274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10657682/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37248900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Alzheimers%20Dis&amp;title=Medial%20temporal%20lobe%20atrophy%20in%20predementia%20Alzheimer's%20disease:%20a%20longitudinal%20multi-site%20study%20comparing%20staging%20and%20A/T/N%20in%20a%20clinical%20research%20cohort&amp;volume=94&amp;issue=1&amp;publication_year=2023&amp;pages=259-279&amp;pmid=37248900&amp;doi=10.3233/JAD-221274&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Chauveau L, Kuhn E, Palix C, et al. Medial temporal lobe subregional atrophy in aging and Alzheimer's disease: a longitudinal study. Front Aging Neurosci. 2021;13:750154. doi: 10.3389/fnagi.2021.750154
</cite> [<a href="https://doi.org/10.3389/fnagi.2021.750154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8554299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34720998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Aging%20Neurosci&amp;title=Medial%20temporal%20lobe%20subregional%20atrophy%20in%20aging%20and%20Alzheimer's%20disease:%20a%20longitudinal%20study&amp;volume=13&amp;publication_year=2021&amp;pages=750154&amp;pmid=34720998&amp;doi=10.3389/fnagi.2021.750154&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1992;55(3):190-194. doi: 10.1136/jnnp.55.3.190
</cite> [<a href="https://doi.org/10.1136/jnnp.55.3.190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1014723/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1564478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol%20Neurosurg%20Psychiatry&amp;title=Association%20of%20atrophy%20of%20the%20medial%20temporal%20lobe%20with%20reduced%20blood%20flow%20in%20the%20posterior%20parietotemporal%20cortex%20in%20patients%20with%20a%20clinical%20and%20pathological%20diagnosis%20of%20Alzheimer's%20disease&amp;volume=55&amp;issue=3&amp;publication_year=1992&amp;pages=190-194&amp;pmid=1564478&amp;doi=10.1136/jnnp.55.3.190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25(34):7709-7717. doi: 10.1523/JNEUROSCI.2177-05.2005
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.2177-05.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6725245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16120771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurosci&amp;title=Molecular,%20structural,%20and%20functional%20characterization%20of%20Alzheimer's%20disease:%20evidence%20for%20a%20relationship%20between%20default%20activity,%20amyloid,%20and%20memory&amp;volume=25&amp;issue=34&amp;publication_year=2005&amp;pages=7709-7717&amp;pmid=16120771&amp;doi=10.1523/JNEUROSCI.2177-05.2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Nestor SM, Rupsingh R, Borrie M, et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain. 2008;131(pt 9):2443-2454. doi: 10.1093/brain/awn146
</cite> [<a href="https://doi.org/10.1093/brain/awn146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2724905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18669512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Ventricular%20enlargement%20as%20a%20possible%20measure%20of%20Alzheimer's%20disease%20progression%20validated%20using%20the%20Alzheimer's%20disease%20neuroimaging%20initiative%20database&amp;volume=131&amp;issue=pt%209&amp;publication_year=2008&amp;pages=2443-2454&amp;pmid=18669512&amp;doi=10.1093/brain/awn146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Mintun MA, Lo AC, Duggan Evans C, et al. Donanemab in early Alzheimer's disease. N Engl J Med. 2021;384(18):1691-1704. doi: 10.1056/NEJMoa2100708
</cite> [<a href="https://doi.org/10.1056/NEJMoa2100708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33720637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Donanemab%20in%20early%20Alzheimer's%20disease&amp;volume=384&amp;issue=18&amp;publication_year=2021&amp;pages=1691-1704&amp;pmid=33720637&amp;doi=10.1056/NEJMoa2100708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer's disease. N Engl J Med. 2023;388(1):9-21. doi: 10.1056/NEJMoa2212948
</cite> [<a href="https://doi.org/10.1056/NEJMoa2212948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36449413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Lecanemab%20in%20early%20Alzheimer's%20disease&amp;volume=388&amp;issue=1&amp;publication_year=2023&amp;pages=9-21&amp;pmid=36449413&amp;doi=10.1056/NEJMoa2212948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Lowe VJ, Mester CT, Lundt ES, et al. Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers. Alzheimers Dement. 2024;20(11):8097-8112. doi: 10.1002/alz.14317
</cite> [<a href="https://doi.org/10.1002/alz.14317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12060152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39392211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement&amp;title=Amyloid%20PET%20detects%20the%20deposition%20of%20brain%20A%CE%B2%20earlier%20than%20CSF%20fluid%20biomarkers&amp;volume=20&amp;issue=11&amp;publication_year=2024&amp;pages=8097-8112&amp;pmid=39392211&amp;doi=10.1002/alz.14317&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Zammit MD, Tudorascu DL, Laymon CM, et al. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome. Neuroimage. 2021;228:117728. doi: 10.1016/j.neuroimage.2021.117728
</cite> [<a href="https://doi.org/10.1016/j.neuroimage.2021.117728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7953340/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33421595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroimage&amp;title=PET%20measurement%20of%20longitudinal%20amyloid%20load%20identifies%20the%20earliest%20stages%20of%20amyloid-beta%20accumulation%20during%20Alzheimer's%20disease%20progression%20in%20Down%20syndrome&amp;volume=228&amp;publication_year=2021&amp;pages=117728&amp;pmid=33421595&amp;doi=10.1016/j.neuroimage.2021.117728&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Mattsson N, Palmqvist S, Stomrud E, Vogel J, Hansson O. Staging beta-amyloid pathology with amyloid positron emission tomography. JAMA Neurol. 2019;76(11):1319-1329. doi: 10.1001/jamaneurol.2019.2214
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2019.2214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6646987/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31314895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Neurol&amp;title=Staging%20beta-amyloid%20pathology%20with%20amyloid%20positron%20emission%20tomography&amp;volume=76&amp;issue=11&amp;publication_year=2019&amp;pages=1319-1329&amp;pmid=31314895&amp;doi=10.1001/jamaneurol.2019.2214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Mattsson-Carlgren N, Andersson E, Janelidze S, et al. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer's disease. Sci Adv. 2020;6(16):eaaz2387. doi: 10.1126/sciadv.aaz2387
</cite> [<a href="https://doi.org/10.1126/sciadv.aaz2387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7159908/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32426454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Adv&amp;title=A%CE%B2%20deposition%20is%20associated%20with%20increases%20in%20soluble%20and%20phosphorylated%20tau%20that%20precede%20a%20positive%20tau%20PET%20in%20Alzheimer's%20disease&amp;volume=6&amp;issue=16&amp;publication_year=2020&amp;pages=eaaz2387&amp;pmid=32426454&amp;doi=10.1126/sciadv.aaz2387&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Palmqvist S, Zetterberg H, Blennow K, et al. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol. 2014;71(10):1282-1289. doi: 10.1001/jamaneurol.2014.1358
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2014.1358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25155658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Neurol&amp;title=Accuracy%20of%20brain%20amyloid%20detection%20in%20clinical%20practice%20using%20cerebrospinal%20fluid%20beta-amyloid%2042:%20a%20cross-validation%20study%20against%20amyloid%20positron%20emission%20tomography&amp;volume=71&amp;issue=10&amp;publication_year=2014&amp;pages=1282-1289&amp;pmid=25155658&amp;doi=10.1001/jamaneurol.2014.1358&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Cicognola C, Brinkmalm G, Wahlgren J, et al. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease. Acta Neuropathol. 2019;137(2):279-296. doi: 10.1007/s00401-018-1948-2
</cite> [<a href="https://doi.org/10.1007/s00401-018-1948-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6514201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30547227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=Novel%20tau%20fragments%20in%20cerebrospinal%20fluid:%20relation%20to%20tangle%20pathology%20and%20cognitive%20decline%20in%20Alzheimer's%20disease&amp;volume=137&amp;issue=2&amp;publication_year=2019&amp;pages=279-296&amp;pmid=30547227&amp;doi=10.1007/s00401-018-1948-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(4):a006213. doi: 10.1101/cshperspect.a006213
</cite> [<a href="https://doi.org/10.1101/cshperspect.a006213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3312396/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22474610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harb%20Perspect%20Med&amp;title=Brain%20imaging%20in%20Alzheimer%20disease&amp;volume=2&amp;issue=4&amp;publication_year=2012&amp;pages=a006213&amp;pmid=22474610&amp;doi=10.1101/cshperspect.a006213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Duits FH, Martinez-Lage P, Paquet C, et al. Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study. Alzheimers Dement. 2016;12(2):154-163. doi: 10.1016/j.jalz.2015.08.003
</cite> [<a href="https://doi.org/10.1016/j.jalz.2015.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26368321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement&amp;title=Performance%20and%20complications%20of%20lumbar%20puncture%20in%20memory%20clinics:%20results%20of%20the%20multicenter%20lumbar%20puncture%20feasibility%20study&amp;volume=12&amp;issue=2&amp;publication_year=2016&amp;pages=154-163&amp;pmid=26368321&amp;doi=10.1016/j.jalz.2015.08.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Tartaglia MC, Rosen HJ, Miller BL. Neuroimaging in dementia. Neurotherapeutics. 2011;8(1):82-92. doi: 10.1007/s13311-010-0012-2
</cite> [<a href="https://doi.org/10.1007/s13311-010-0012-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3026935/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21274688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurotherapeutics&amp;title=Neuroimaging%20in%20dementia&amp;volume=8&amp;issue=1&amp;publication_year=2011&amp;pages=82-92&amp;pmid=21274688&amp;doi=10.1007/s13311-010-0012-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Masdeu JC, Pascual B. Neuroimaging of disorders leading to dementia. Curr Neurol Neurosci Rep. 2008;8(6):443-444. doi: 10.1007/s11910-008-0069-z
</cite> [<a href="https://doi.org/10.1007/s11910-008-0069-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18957178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Neurol%20Neurosci%20Rep&amp;title=Neuroimaging%20of%20disorders%20leading%20to%20dementia&amp;volume=8&amp;issue=6&amp;publication_year=2008&amp;pages=443-444&amp;pmid=18957178&amp;doi=10.1007/s11910-008-0069-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Chételat G, Villemagne VL, Villain N, et al. Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition. Neurology. 2012;78(7):477-484. doi: 10.1212/WNL.0b013e318246d67a
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e318246d67a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22302548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Accelerated%20cortical%20atrophy%20in%20cognitively%20normal%20elderly%20with%20high%20beta-amyloid%20deposition&amp;volume=78&amp;issue=7&amp;publication_year=2012&amp;pages=477-484&amp;pmid=22302548&amp;doi=10.1212/WNL.0b013e318246d67a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Nosheny RL, Insel PS, Mattsson N, et al. Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults. Neurobiol Aging. 2019;82:110-119. doi: 10.1016/j.neurobiolaging.2019.07.005
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2019.07.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7198229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31437719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol%20Aging&amp;title=Associations%20among%20amyloid%20status,%20age,%20and%20longitudinal%20regional%20brain%20atrophy%20in%20cognitively%20unimpaired%20older%20adults&amp;volume=82&amp;publication_year=2019&amp;pages=110-119&amp;pmid=31437719&amp;doi=10.1016/j.neurobiolaging.2019.07.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Chun MY, Kim GH, Park HK, et al. Predictive scale for amyloid PET positivity based on clinical and MRI variables in patients with amnestic mild cognitive impairment. J Clin Med. 2022;11(12):3433. doi: 10.3390/jcm11123433
</cite> [<a href="https://doi.org/10.3390/jcm11123433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9224873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35743503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=Predictive%20scale%20for%20amyloid%20PET%20positivity%20based%20on%20clinical%20and%20MRI%20variables%20in%20patients%20with%20amnestic%20mild%20cognitive%20impairment&amp;volume=11&amp;issue=12&amp;publication_year=2022&amp;pages=3433&amp;pmid=35743503&amp;doi=10.3390/jcm11123433&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Kang SH, Cheon BK, Kim JS, et al. Machine learning for the prediction of amyloid positivity in amnestic mild cognitive impairment. J Alzheimers Dis. 2021;80(1):143-157. doi: 10.3233/JAD-201092
</cite> [<a href="https://doi.org/10.3233/JAD-201092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33523003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Alzheimers%20Dis&amp;title=Machine%20learning%20for%20the%20prediction%20of%20amyloid%20positivity%20in%20amnestic%20mild%20cognitive%20impairment&amp;volume=80&amp;issue=1&amp;publication_year=2021&amp;pages=143-157&amp;pmid=33523003&amp;doi=10.3233/JAD-201092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>van de Pol LA, Hensel A, Barkhof F, Gertz HJ, Scheltens P, van der Flier WM. Hippocampal atrophy in Alzheimer disease: age matters. Neurology. 2006;66(2):236-238. doi: 10.1212/01.wnl.0000194240.47892.4d
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000194240.47892.4d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16434661/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Hippocampal%20atrophy%20in%20Alzheimer%20disease:%20age%20matters&amp;volume=66&amp;issue=2&amp;publication_year=2006&amp;pages=236-238&amp;pmid=16434661&amp;doi=10.1212/01.wnl.0000194240.47892.4d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Barkhof F, Polvikoski TM, van Straaten EC, et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology. 2007;69(15):1521-1527. doi: 10.1212/01.wnl.0000277459.83543.99
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000277459.83543.99" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17923614/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=The%20significance%20of%20medial%20temporal%20lobe%20atrophy:%20a%20postmortem%20MRI%20study%20in%20the%20very%20old&amp;volume=69&amp;issue=15&amp;publication_year=2007&amp;pages=1521-1527&amp;pmid=17923614&amp;doi=10.1212/01.wnl.0000277459.83543.99&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Wolz R, Julkunen V, Koikkalainen J, et al. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One. 2011;6(10):e25446. doi: 10.1371/journal.pone.0025446
</cite> [<a href="https://doi.org/10.1371/journal.pone.0025446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3192759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22022397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Multi-method%20analysis%20of%20MRI%20images%20in%20early%20diagnostics%20of%20Alzheimer's%20disease&amp;volume=6&amp;issue=10&amp;publication_year=2011&amp;pages=e25446&amp;pmid=22022397&amp;doi=10.1371/journal.pone.0025446&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. A European model for an organised risk-stratified early detection programme for prostate cancer. Eur Urol Oncol. 2021;4(5):731-739. doi: 10.1016/j.euo.2021.06.006
</cite> [<a href="https://doi.org/10.1016/j.euo.2021.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34364829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Urol%20Oncol&amp;title=A%20European%20model%20for%20an%20organised%20risk-stratified%20early%20detection%20programme%20for%20prostate%20cancer&amp;volume=4&amp;issue=5&amp;publication_year=2021&amp;pages=731-739&amp;pmid=34364829&amp;doi=10.1016/j.euo.2021.06.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma phospho-tau217 for alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772-781. doi: 10.1001/jama.2020.12134
</cite> [<a href="https://doi.org/10.1001/jama.2020.12134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7388060/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32722745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Discriminative%20accuracy%20of%20plasma%20phospho-tau217%20for%20alzheimer%20disease%20vs%20other%20neurodegenerative%20disorders&amp;volume=324&amp;issue=8&amp;publication_year=2020&amp;pages=772-781&amp;pmid=32722745&amp;doi=10.1001/jama.2020.12134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Milà-Alomà M, Ashton NJ, Shekari M, et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer's disease. Nat Med. 2022;28(9):1797-1801. doi: 10.1038/s41591-022-01925-w
</cite> [<a href="https://doi.org/10.1038/s41591-022-01925-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9499867/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35953717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Plasma%20p-tau231%20and%20p-tau217%20as%20state%20markers%20of%20amyloid-beta%20pathology%20in%20preclinical%20Alzheimer's%20disease&amp;volume=28&amp;issue=9&amp;publication_year=2022&amp;pages=1797-1801&amp;pmid=35953717&amp;doi=10.1038/s41591-022-01925-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>De Meyer S, Schaeverbeke JM, Luckett ES, et al. Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET. Brain Commun. 2024;6(4):fcae162. doi: 10.1093/braincomms/fcae162
</cite> [<a href="https://doi.org/10.1093/braincomms/fcae162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11267224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39051027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Commun&amp;title=Plasma%20pTau181%20and%20pTau217%20predict%20asymptomatic%20amyloid%20accumulation%20equally%20well%20as%20amyloid%20PET&amp;volume=6&amp;issue=4&amp;publication_year=2024&amp;pages=fcae162&amp;pmid=39051027&amp;doi=10.1093/braincomms/fcae162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Jack CR, Wiste HJ, Algeciras-Schimnich A, et al. Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023;146(5):2029-2044. doi: 10.1093/brain/awad042
</cite> [<a href="https://doi.org/10.1093/brain/awad042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10151195/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36789483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Predicting%20amyloid%20PET%20and%20tau%20PET%20stages%20with%20plasma%20biomarkers&amp;volume=146&amp;issue=5&amp;publication_year=2023&amp;pages=2029-2044&amp;pmid=36789483&amp;doi=10.1093/brain/awad042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Jang H, Shin D, Kim Y, et al. Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD): a cohort for dementia research and ethnic-specific insights. Dement Neurocogn Disord. 2024;23(4):212-223. doi: 10.12779/dnd.2024.23.4.212
</cite> [<a href="https://doi.org/10.12779/dnd.2024.23.4.212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11538854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39512701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dement%20Neurocogn%20Disord&amp;title=Korea-Registries%20to%20Overcome%20Dementia%20and%20Accelerate%20Dementia%20Research%20(K-ROAD):%20a%20cohort%20for%20dementia%20research%20and%20ethnic-specific%20insights&amp;volume=23&amp;issue=4&amp;publication_year=2024&amp;pages=212-223&amp;pmid=39512701&amp;doi=10.12779/dnd.2024.23.4.212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Ryu HJ, Yang DW. The Seoul Neuropsychological Screening Battery (SNSB) for comprehensive neuropsychological assessment. Dement Neurocogn Disord. 2023;22:1-15. doi: 10.12779/dnd.2023.22.1.1
</cite> [<a href="https://doi.org/10.12779/dnd.2023.22.1.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9939572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36814700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dement%20Neurocogn%20Disord&amp;title=The%20Seoul%20Neuropsychological%20Screening%20Battery%20(SNSB)%20for%20comprehensive%20neuropsychological%20assessment&amp;volume=22&amp;publication_year=2023&amp;pages=1-15&amp;pmid=36814700&amp;doi=10.12779/dnd.2023.22.1.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308. doi: 10.1001/archneur.56.3.303
</cite> [<a href="https://doi.org/10.1001/archneur.56.3.303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10190820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Neurol&amp;title=Mild%20cognitive%20impairment:%20clinical%20characterization%20and%20outcome&amp;volume=56&amp;issue=3&amp;publication_year=1999&amp;pages=303-308&amp;pmid=10190820&amp;doi=10.1001/archneur.56.3.303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270-279. doi: 10.1016/j.jalz.2011.03.008
</cite> [<a href="https://doi.org/10.1016/j.jalz.2011.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3312027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21514249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement&amp;title=The%20diagnosis%20of%20mild%20cognitive%20impairment%20due%20to%20Alzheimer's%20disease:%20recommendations%20from%20the%20National%20Institute%20on%20Aging-Alzheimer's%20Association%20workgroups%20on%20diagnostic%20guidelines%20for%20Alzheimer's%20disease&amp;volume=7&amp;issue=3&amp;publication_year=2011&amp;pages=270-279&amp;pmid=21514249&amp;doi=10.1016/j.jalz.2011.03.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263-269. doi: 10.1016/j.jalz.2011.03.005
</cite> [<a href="https://doi.org/10.1016/j.jalz.2011.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3312024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21514250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement&amp;title=The%20diagnosis%20of%20dementia%20due%20to%20Alzheimer's%20disease:%20recommendations%20from%20the%20National%20Institute%20on%20Aging-Alzheimer's%20Association%20workgroups%20on%20diagnostic%20guidelines%20for%20Alzheimer's%20disease&amp;volume=7&amp;issue=3&amp;publication_year=2011&amp;pages=263-269&amp;pmid=21514250&amp;doi=10.1016/j.jalz.2011.03.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351-356. doi: 10.2214/ajr.149.2.351
</cite> [<a href="https://doi.org/10.2214/ajr.149.2.351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3496763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=MR%20signal%20abnormalities%20at%201.5%20T%20in%20Alzheimer's%20dementia%20and%20normal%20aging&amp;volume=149&amp;issue=2&amp;publication_year=1987&amp;pages=351-356&amp;pmid=3496763&amp;doi=10.2214/ajr.149.2.351&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Alzheimer's Disease Neuroimaging Initiative (ADNI). Accessed
July 26, 2025. <a href="https://adni-info.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://adni-info.org</a>.</cite>
</li>
<li id="R41">
<span class="label">41.</span><cite>Global Alzheimer’s Association 
Interactive Network (GAAIN). Accessed
July 26, 2025. <a href="https://www.gaain.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.gaain.org/</a>.</cite>
</li>
<li id="R42">
<span class="label">42.</span><cite> ADNI.
Image data and methods. Accessed
July 26, 2025. <a href="https://adni.loni.usc.edu/methods/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://adni.loni.usc.edu/methods/</a>.</cite>
</li>
<li id="R43">
<span class="label">43.</span><cite>Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18(2):203-211. doi: 10.1038/s41592-020-01008-z
</cite> [<a href="https://doi.org/10.1038/s41592-020-01008-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33288961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Methods&amp;title=nnU-Net:%20a%20self-configuring%20method%20for%20deep%20learning-based%20biomedical%20image%20segmentation&amp;volume=18&amp;issue=2&amp;publication_year=2021&amp;pages=203-211&amp;pmid=33288961&amp;doi=10.1038/s41592-020-01008-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>R Core Team. R : A language and environment for statistical computing. Accessed
July 26, 2025. <a href="https://www.r-project.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.r-project.org</a>.</cite>
</li>
<li id="R45">
<span class="label">45.</span><cite>Scikit-learn: Machine learning in Python. Accessed
July 26, 2025. <a href="https://scikit-learn.org/stable/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scikit-learn.org/stable/index.html</a>.</cite>
</li>
<li id="R46">
<span class="label">46.</span><cite>Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain. 2011;134(pt 4):1077-1088. doi: 10.1093/brain/awr044
</cite> [<a href="https://doi.org/10.1093/brain/awr044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3069703/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21429865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Spatial%20patterns%20of%20brain%20amyloid-beta%20burden%20and%20atrophy%20rate%20associations%20in%20mild%20cognitive%20impairment&amp;volume=134&amp;issue=pt%204&amp;publication_year=2011&amp;pages=1077-1088&amp;pmid=21429865&amp;doi=10.1093/brain/awr044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R47">
<span class="label">47.</span><cite>Pekkala T, Hall A, Ngandu T, et al. Detecting amyloid positivity in elderly with increased risk of cognitive decline. Front Aging Neurosci. 2020;12:228. doi: 10.3389/fnagi.2020.00228
</cite> [<a href="https://doi.org/10.3389/fnagi.2020.00228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7406705/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32848707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Aging%20Neurosci&amp;title=Detecting%20amyloid%20positivity%20in%20elderly%20with%20increased%20risk%20of%20cognitive%20decline&amp;volume=12&amp;publication_year=2020&amp;pages=228&amp;pmid=32848707&amp;doi=10.3389/fnagi.2020.00228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R48">
<span class="label">48.</span><cite>Loreto F, Gontsarova A, Scott G, et al. Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort. Ann Clin Transl Neurol. 2023;10(4):619-631. doi: 10.1002/acn3.51749
</cite> [<a href="https://doi.org/10.1002/acn3.51749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10109315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36872523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Clin%20Transl%20Neurol&amp;title=Visual%20atrophy%20rating%20scales%20and%20amyloid%20PET%20status%20in%20an%20Alzheimer's%20disease%20clinical%20cohort&amp;volume=10&amp;issue=4&amp;publication_year=2023&amp;pages=619-631&amp;pmid=36872523&amp;doi=10.1002/acn3.51749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R49">
<span class="label">49.</span><cite>Imabayashi E, Ishii K, Toyohara J, et al. Possibility of enlargement in left medial temporal areas against cerebral amyloid deposition observed during preclinical stage. Front Aging Neurosci. 2022;14:847094. doi: 10.3389/fnagi.2022.847094
</cite> [<a href="https://doi.org/10.3389/fnagi.2022.847094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9063485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35517046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Aging%20Neurosci&amp;title=Possibility%20of%20enlargement%20in%20left%20medial%20temporal%20areas%20against%20cerebral%20amyloid%20deposition%20observed%20during%20preclinical%20stage&amp;volume=14&amp;publication_year=2022&amp;pages=847094&amp;pmid=35517046&amp;doi=10.3389/fnagi.2022.847094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R50">
<span class="label">50.</span><cite>Asken BM, DeSimone JC, Wang WE, et al. Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults. Alzheimers Dement (Amst). 2024;16(3):e12617. doi: 10.1002/dad2.12617
</cite> [<a href="https://doi.org/10.1002/dad2.12617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11253830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39021585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement%20(Amst)&amp;title=Plasma%20p-tau217%20concordance%20with%20amyloid%20PET%20among%20ethnically%20diverse%20older%20adults&amp;volume=16&amp;issue=3&amp;publication_year=2024&amp;pages=e12617&amp;pmid=39021585&amp;doi=10.1002/dad2.12617&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R51">
<span class="label">51.</span><cite>Molina-Henry D, Langford O, Donohue MC, et al. Relationship between plasma P-Tau217 and amyloid PET in racial and ethnic underrepresented groups (RE-URG) compared with non RE-URG in LEARN and A4. J Prev Alzheimers Dis. 2024;11(4):831-837. doi: 10.14283/jpad.2024.124
</cite> [<a href="https://doi.org/10.14283/jpad.2024.124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11266219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39044491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Prev%20Alzheimers%20Dis&amp;title=Relationship%20between%20plasma%20P-Tau217%20and%20amyloid%20PET%20in%20racial%20and%20ethnic%20underrepresented%20groups%20(RE-URG)%20compared%20with%20non%20RE-URG%20in%20LEARN%20and%20A4&amp;volume=11&amp;issue=4&amp;publication_year=2024&amp;pages=831-837&amp;pmid=39044491&amp;doi=10.14283/jpad.2024.124&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R52">
<span class="label">52.</span><cite>Brum WS, Cullen NC, Janelidze S, et al. A two-step workflow based on plasma p-tau217 to screen for amyloid beta positivity with further confirmatory testing only in uncertain cases. Nat Aging. 2023;3(9):1079-1090. doi: 10.1038/s43587-023-00471-5
</cite> [<a href="https://doi.org/10.1038/s43587-023-00471-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10501903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37653254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Aging&amp;title=A%20two-step%20workflow%20based%20on%20plasma%20p-tau217%20to%20screen%20for%20amyloid%20beta%20positivity%20with%20further%20confirmatory%20testing%20only%20in%20uncertain%20cases&amp;volume=3&amp;issue=9&amp;publication_year=2023&amp;pages=1079-1090&amp;pmid=37653254&amp;doi=10.1038/s43587-023-00471-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R53">
<span class="label">53.</span><cite>Karikari TK, Ashton NJ, Brinkmalm G, et al. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat Rev Neurol. 2022;18(7):400-418. doi: 10.1038/s41582-022-00665-2
</cite> [<a href="https://doi.org/10.1038/s41582-022-00665-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35585226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Neurol&amp;title=Blood%20phospho-tau%20in%20Alzheimer%20disease:%20analysis,%20interpretation,%20and%20clinical%20utility&amp;volume=18&amp;issue=7&amp;publication_year=2022&amp;pages=400-418&amp;pmid=35585226&amp;doi=10.1038/s41582-022-00665-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R54">
<span class="label">54.</span><cite>Therriault J, Servaes S, Tissot C, et al. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease. Alzheimers Dement. 2023;19(11):4967-4977. doi: 10.1002/alz.13026
</cite> [<a href="https://doi.org/10.1002/alz.13026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10587362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37078495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement&amp;title=Equivalence%20of%20plasma%20p-tau217%20with%20cerebrospinal%20fluid%20in%20the%20diagnosis%20of%20Alzheimer's%20disease&amp;volume=19&amp;issue=11&amp;publication_year=2023&amp;pages=4967-4977&amp;pmid=37078495&amp;doi=10.1002/alz.13026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R55">
<span class="label">55.</span><cite>Butler Pagnotti RM, Pudumjee SB, Cross CL, Miller JB. Cognitive and clinical characteristics of patients with limbic-predominant age-related TDP-43 encephalopathy. Neurology. 2023;100(19):e2027-e2035. doi: 10.1212/WNL.0000000000207159
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000207159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10186224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36941071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Cognitive%20and%20clinical%20characteristics%20of%20patients%20with%20limbic-predominant%20age-related%20TDP-43%20encephalopathy&amp;volume=100&amp;issue=19&amp;publication_year=2023&amp;pages=e2027-e2035&amp;pmid=36941071&amp;doi=10.1212/WNL.0000000000207159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data sets generated and analyzed during this study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Neurology are provided here courtesy of <strong>American Academy of Neurology</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1212/WNL.0000000000213954"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/WNL-2025-200353.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12367417/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12367417/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367417%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367417/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12367417/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12367417/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40829110/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12367417/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40829110/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12367417/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12367417/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="LCvDHYU9MsY0UjHjV8cW3k7IgvQqCQvh3NKAE9IwjtFzuHKGiFJUOEj2v1FfuH5a">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
